Report cover image

Alzheimer’s Disease Treatment Global Market Report 2024

Publisher The Business Research Company
Published Feb 23, 2024
Length 250 Pages
SKU # BRC18558428

Description

Alzheimer’s Disease Treatment Global Market Report 2024

Including: 1) By Drug Class: Cholinergic; Memantine; Combined Drug; AChE inhibitors; Immunoglobulins 2) By Drug Type: Cholinesterase Inhibitors; NMDA Receptor Antagonists 3) By Therapeutics: Cholinesterase Inhibitors; NMDA Receptor AntagonistsCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Novartis AG


Alzheimer’s Disease Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alzheimer’s disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for alzheimer’s disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alzheimer’s disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of covid 19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Drug Class: Cholinergic; Memantine; Combined Drug; AChE inhibitors; Immunoglobulins

2) By Drug Type: Cholinesterase Inhibitors; NMDA Receptor Antagonists

3) By Therapeutics: Cholinesterase Inhibitors; NMDA Receptor Antagonists; Other Therapeutics

Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Alzheimer’s Disease Treatment Market Characteristics
3. Alzheimer’s Disease Treatment Market Trends And Strategies
4. Alzheimer’s Disease Treatment Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Alzheimer’s Disease Treatment Market Size and Growth
5.1. Global Alzheimer’s Disease Treatment Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Alzheimer’s Disease Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Alzheimer’s Disease Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Alzheimer’s Disease Treatment Market Segmentation
6.1. Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cholinergic
Memantine
Combined Drug
AChE inhibitors
Immunoglobulins
6.2. Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cholinesterase Inhibitors
NMDA Receptor Antagonists
6.3. Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cholinesterase Inhibitors
NMDA Receptor Antagonists
Other Therapeutics
7. Alzheimer’s Disease Treatment Market Regional And Country Analysis
7.1. Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Alzheimer’s Disease Treatment Market
8.1. Asia-Pacific Alzheimer’s Disease Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Alzheimer’s Disease Treatment Market
9.1. China Alzheimer’s Disease Treatment Market Overview
9.2. China Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Alzheimer’s Disease Treatment Market
10.1. India Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Alzheimer’s Disease Treatment Market
11.1. Japan Alzheimer’s Disease Treatment Market Overview
11.2. Japan Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Alzheimer’s Disease Treatment Market
12.1. Australia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Alzheimer’s Disease Treatment Market
13.1. Indonesia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Alzheimer’s Disease Treatment Market
14.1. South Korea Alzheimer’s Disease Treatment Market Overview
14.2. South Korea Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Alzheimer’s Disease Treatment Market
15.1. Western Europe Alzheimer’s Disease Treatment Market Overview
15.2. Western Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Alzheimer’s Disease Treatment Market
16.1. UK Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Alzheimer’s Disease Treatment Market
17.1. Germany Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Alzheimer’s Disease Treatment Market
18.1. France Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Alzheimer’s Disease Treatment Market
19.1. Italy Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Alzheimer’s Disease Treatment Market
20.1. Spain Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Alzheimer’s Disease Treatment Market
21.1. Eastern Europe Alzheimer’s Disease Treatment Market Overview
21.2. Eastern Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Alzheimer’s Disease Treatment Market
22.1. Russia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Alzheimer’s Disease Treatment Market
23.1. North America Alzheimer’s Disease Treatment Market Overview
23.2. North America Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Alzheimer’s Disease Treatment Market
24.1. USA Alzheimer’s Disease Treatment Market Overview
24.2. USA Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Alzheimer’s Disease Treatment Market
25.1. Canada Alzheimer’s Disease Treatment Market Overview
25.2. Canada Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Alzheimer’s Disease Treatment Market
26.1. South America Alzheimer’s Disease Treatment Market Overview
26.2. South America Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Alzheimer’s Disease Treatment Market
27.1. Brazil Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Alzheimer’s Disease Treatment Market
28.1. Middle East Alzheimer’s Disease Treatment Market Overview
28.2. Middle East Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Alzheimer’s Disease Treatment Market
29.1. Africa Alzheimer’s Disease Treatment Market Overview
29.2. Africa Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Alzheimer’s Disease Treatment Market Competitive Landscape And Company Profiles
30.1. Alzheimer’s Disease Treatment Market Competitive Landscape
30.2. Alzheimer’s Disease Treatment Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. F. Hoffmann-La Roche Ltd.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. AbbVie Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Bayer AG
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Novartis AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Alzheimer’s Disease Treatment Market Other Major And Innovative Companies
31.1. Bristol-Myers Squibb Company
31.2. AstraZeneca plc
31.3. Merck Sharp & Dohme Corp.
31.4. Takeda Pharmaceutical Company Limited
31.5. Eli Lilly and Company
31.6. Amgen Inc.
31.7. Teva Pharmaceutical Industries Ltd.
31.8. Biogen Inc.
31.9. UCB S.A.
31.10. Eisai Co. Ltd.
31.11. Forest Laboratories LLC
31.12. Ono Pharmaceutical Co. Ltd.
31.13. H. Lundbeck A/S
31.14. Allergan plc
31.15. Merz Pharma GmbH & Co. KGaA
32. Global Alzheimer’s Disease Treatment Market Competitive Benchmarking
33. Global Alzheimer’s Disease Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Alzheimer’s Disease Treatment Market
35. Alzheimer’s Disease Treatment Market Future Outlook and Potential Analysis
35.1 Alzheimer’s Disease Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Alzheimer’s Disease Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Alzheimer’s Disease Treatment Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us